Otsuka enters deal with Mylan to bring MDR TB drug to India Industry-The Economic Times — August 24, 2017 comments off The Drug Controller General of India has granted Mylan’s subsidiary approval for the drug, according to a release by the company. The drug, delamanid, was discovered and developed by Otsuka.